Tumor-Agnostic First In England As NICE Reverses Vitrakvi Rejection

 
• By Neena Brizmohun
  
Price
Bayer dropped the price it was asking for Vitrakvi • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Market Access